Abstract
Summary
Five human patients' sera containing antiganglioside activity were examined with various ganglioside preparations utilizing hemagglutination and hemagglutination inhibition techniques. The results indicate that the activity in these cases is specific for monosialoganglioside.
Get full access to this article
View all access options for this article.